Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
International Journal of Clinical Oncology
|
October 2, 2021
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study
Yoichiro Tohi, Takuma Kato, Masaki Nakamura, et al.
Japanese Journal of Clinical Oncology
|
October 16, 2023
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
Yoichiro Tohi, Takuma Kato, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology
|
July 27, 2023
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort
Yoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
BJU International
|
January 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study
Takuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
Nutrition and Cancer
|
July 3, 2026
Dynamic Loss of Psoas Muscle Volume During Induction Chemotherapy Predicts Survival in Patients with Advanced Urothelial Carcinoma Receiving Avelumab Maintenance: A Multicenter Retrospective Study
Ryutaro Shimizu, Shuichi Morizane, Noriya Yamaguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 8, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN Study
Leandro Blas, Masaki Shiota, Takuma Kato, et al.
Urologic Oncology
|
June 11, 2021
Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study
Yoichiro Tohi, Takuma Kato, Akira Yokomizo, et al.
International Journal of Clinical Oncology
|
August 10, 2020
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study
Yoichiro Tohi, Takuma Kato, Ryuji Matsumoto, et al.
Japanese Journal of Clinical Oncology
|
June 6, 2022
Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study
Yoichiro Tohi, Takuma Kato, Jimpei Miyakawa, et al.
International Journal of Clinical Oncology
|
February 28, 2024
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study
Rikiya Taoka, Masaki Kamada, Kazuyoshi Izumi, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
International Journal of Clinical Oncology
|
October 2, 2021
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study
Yoichiro Tohi, Takuma Kato, Masaki Nakamura, et al.
Japanese Journal of Clinical Oncology
|
October 16, 2023
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
Yoichiro Tohi, Takuma Kato, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology
|
July 27, 2023
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort
Yoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
BJU International
|
January 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study
Takuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
Nutrition and Cancer
|
July 3, 2026
Dynamic Loss of Psoas Muscle Volume During Induction Chemotherapy Predicts Survival in Patients with Advanced Urothelial Carcinoma Receiving Avelumab Maintenance: A Multicenter Retrospective Study
Ryutaro Shimizu, Shuichi Morizane, Noriya Yamaguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 8, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN Study
Leandro Blas, Masaki Shiota, Takuma Kato, et al.
Urologic Oncology
|
June 11, 2021
Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study
Yoichiro Tohi, Takuma Kato, Akira Yokomizo, et al.
International Journal of Clinical Oncology
|
August 10, 2020
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study
Yoichiro Tohi, Takuma Kato, Ryuji Matsumoto, et al.
Japanese Journal of Clinical Oncology
|
June 6, 2022
Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study
Yoichiro Tohi, Takuma Kato, Jimpei Miyakawa, et al.
International Journal of Clinical Oncology
|
February 28, 2024
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study
Rikiya Taoka, Masaki Kamada, Kazuyoshi Izumi, et al.
Page
of 9